Hims & Hers Health, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 10 →Insiders1 insider bought $1.2M in 1 open-market buy. 9 insiders sold $24.9M, 41 of 42 sales on a 10b5-1 plan.→HoldersBlackRock $995.2MVanguard Portfolio $366.1MVanguard $330.8M→Financing →PeersClosest companies: ECOR, SKIN, GDRX→
From the filings
Figures
- Revenue
- $2.58Blast 12 months
- Net income
- −$142.0Mlast 12 months
- Operating cash flow
- $280.3Mlast 12 months
- Cash and equivalents
- $609.8Mat the last balance sheet